Adage Capital Partners’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.4M Sell
65,807
-145,300
-69% -$31.8M 0.02% 528
2025
Q1
$47.3M Sell
211,107
-31,600
-13% -$7.07M 0.09% 237
2024
Q4
$79.5M Buy
242,707
+64,300
+36% +$21.1M 0.14% 142
2024
Q3
$53.6M Buy
178,407
+8,500
+5% +$2.55M 0.09% 221
2024
Q2
$56M Sell
169,907
-27,700
-14% -$9.12M 0.1% 200
2024
Q1
$78.2M Buy
197,607
+125,700
+175% +$49.7M 0.15% 142
2023
Q4
$25.3M Sell
71,907
-1,500
-2% -$528K 0.05% 356
2023
Q3
$27.5M Sell
73,407
-600
-0.8% -$225K 0.06% 311
2023
Q2
$28.3M Sell
74,007
-75,100
-50% -$28.7M 0.06% 319
2023
Q1
$51.7M Buy
149,107
+73,800
+98% +$25.6M 0.12% 207
2022
Q4
$17.7M Sell
75,307
-100
-0.1% -$23.5K 0.04% 475
2022
Q3
$18.6M Sell
75,407
-1,700
-2% -$418K 0.05% 428
2022
Q2
$23.3M Sell
77,107
-200
-0.3% -$60.5K 0.05% 381
2022
Q1
$31.8M Sell
77,307
-1,600
-2% -$657K 0.06% 325
2021
Q4
$37M Sell
78,907
-500
-0.6% -$235K 0.07% 300
2021
Q3
$33.7M Sell
79,407
-1,100
-1% -$467K 0.07% 299
2021
Q2
$28.9M Buy
80,507
+24,700
+44% +$8.87M 0.06% 348
2021
Q1
$15.7M Sell
55,807
-1,500
-3% -$423K 0.03% 536
2020
Q4
$16.2M Sell
57,307
-25,250
-31% -$7.15M 0.04% 471
2020
Q3
$22.7M Sell
82,557
-2,700
-3% -$742K 0.06% 343
2020
Q2
$19.4M Buy
+85,257
New +$19.4M 0.05% 389
2019
Q1
Sell
-130,000
Closed -$12.7M 743
2018
Q4
$12.7M Sell
130,000
-20,000
-13% -$1.96M 0.04% 450
2018
Q3
$18.5M Buy
+150,000
New +$18.5M 0.04% 417